NCT03075501 is a Phase 4 clinical trial of Paired in Substance-Related Disorders, sponsored by University of Illinois at Chicago.

Who is sponsoring NCT03075501?

NCT03075501 is sponsored by University of Illinois at Chicago.

What drugs are being tested in NCT03075501?

Interventions in NCT03075501: Paired, Stimulant or sedative, Placebo.

What condition does NCT03075501 study?

NCT03075501 studies Substance-Related Disorders.

Is NCT03075501 still recruiting?

NCT03075501 is currently completed. Last updated 28 April 2021.

Are results published for NCT03075501?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-04-28 · How we verify

NCT03075501

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drug Contextual Conditioning With in Humans: Causes and Consequences

Completed Phase 4 Results posted Last updated 28 April 2021

What this trial tests

Phase 4 trial testing Paired in Substance-Related Disorders in 133 participants. Completed in 1 July 2020.

Timeline

1 November 2015

Primary endpoint
1 July 2020

1 July 2020

Quick facts

Lead sponsor	University of Illinois at Chicago
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	133
Start date	1 November 2015
Primary completion	1 July 2020
Estimated completion	1 July 2020
Sites	1 location across United States

Drugs / interventions tested

Paired
Stimulant or sedative — full drug profile →
Placebo

Conditions studied

Substance-Related Disorders — all drugs for Substance-Related Disorders →

Sponsor

University of Illinois at Chicago

Who can join

Adults 18 to 40, any sex, with Substance-Related Disorders. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Change in Time Spent in Drug-paired Room
Time frame: Measured through study completion (maximum 5 weeks).
The amount of time spent in the two testing rooms is assessed during a 10min exploration test conducted at the orientation session (pre-test) and again at the testing session (post-test). Between the pre- and post-tests, participants complete 4 drug administration sessions; 2 with 20mg MA, 2 with 0mg MA. The Paired Group always receives 20mg MA in the room they spent the least time in at pre-test,

Sponsor's own description

The purpose of the study is to determine how associations between drugs and the places where they are experienced influence drug seeking, mood and acute drug responses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Substance-Related Disorders

Currently open trials in the same condition.

NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
NCT06387290 — Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits · Phase 3 · recruiting
NCT05763537 — Understanding the Role of Doulas in Supporting People With PMADs · NA · recruiting
NCT06685003 — Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families · NA · recruiting

Other University of Illinois at Chicago trials

Trials by the same sponsor.

NCT07498322 — Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System · NA · not yet recruiting
NCT07387705 — On Track for Wellness (OTW) Stepped Wedge Cluster Randomized Trial · Phase 1 · not yet recruiting
NCT07504120 — The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple Sclerosis · NA · not yet recruiting
NCT07160582 — Cognitive-Motor Training for AD/ADRD Prevention · NA · not yet recruiting
NCT07498348 — Apple Watch Evaluation of Endodontics Occupational Stress · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03075501 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Chicago
Last refreshed: 28 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03075501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing